Veradermics MANE
NYSE MANE
$132.21 +5.11 (+4.02%)
As of: Oct 21, 2026 · 9:58 AM EDT

Veradermics (MANE) EBT (2025 - 2026)

Updated

Veradermics' EBT came in at -$23.5 million for Q2 2026, compared with -$15.65 million a year earlier.

Analysis

Veradermics (MANE) EBT (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Veradermics reported EBT of -$78.78 million; for FY2025, it was -$70 million.

  • Going back by year, EBT was -$26.49 million in FY2024.
  • The five-year range for quarterly EBT is -$27.23 million (Q1 2026) to -$12.4 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Eli Lilly 1,136.25 Bn 1,104.84 Bn 19.71 Bn 9.25 Bn
2 Johnson & Johnson 615.56 Bn 534.09 Bn 17.26 Bn 6.75 Bn
3 AbbVie 506.32 Bn 479.44 Bn 12.70 Bn 4.28 Bn
4 Merck 367.72 Bn 322.10 Bn 12.21 Bn -683.00 Mn
5 Novartis Ag 298.15 Bn 262.14 Bn 11.24 Bn 4.27 Bn
6 Astrazeneca 262.32 Bn 236.01 Bn 12.86 Bn 2.80 Bn
7 Amgen 236.40 Bn 191.80 Bn 7.24 Bn 2.77 Bn
8 Gilead Sciences 191.30 Bn 165.50 Bn 6.22 Bn -10.25 Bn
9 Pfizer 170.97 Bn 117.62 Bn 10.94 Bn -653.00 Mn
10 Veradermics 5.34 Bn 3.94 Bn - -23.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -23.50 Mn
Mar 31, 2026 -27.23 Mn
Jun 30, 2025 -15.65 Mn
Mar 31, 2025 -12.40 Mn
API Access

Veradermics EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=MANE&period=max&api_key=YOUR_API_KEY